Excision of a subcutaneous soft tissue tumor of the face or scalp measuring 2 cm or greater.

Verified May 8, 2026 · 5 sources ↓

Medicare: $323.99
Work RVU: 4.34
Global, days: 90
Region: Other

Drawn from CMSMdclarityPayerpriceAAPC

Documentation requirements

What must appear in the operative or office note to support the claim.

Source · Editorial brief grounded in 5 cited references ↓

Measured tumor size documented at or exceeding 2 cm — measurement must appear in the operative or procedure note, not just the pathology report.
Anatomic location specified as face or scalp; general 'head' documentation is insufficient for this code family.
Depth of excision confirmed as subcutaneous; deeper fascial or intramuscular excision maps to different codes.
Operative note describes the surgical approach, margins taken, and method of closure.
Pathology specimen sent and report retained in the record to support medical necessity.
Pre-operative diagnosis establishing clinical indication (e.g., lipoma, epidermoid cyst, soft tissue neoplasm) with corresponding ICD-10 code.

Applicable modifiers

Modifiers commonly billed with this code.

Source · AMA CPT modifier descriptors · CMS NCCI Policy Manual

22 Increased complexity 25 Significant separate E/M 50 Bilateral procedure 51 Multiple procedures 58 Staged or related 59 Distinct service 76 Repeat, same physician 77 Repeat, another physician 78 Unplanned return — related 79 Unrelated during global LT Left side RT Right side

What this code covers

Source · Editorial summary grounded in 5 cited references ↓

CPT 21012 covers surgical removal of a subcutaneous soft tissue tumor on the face or scalp when the lesion measures 2 cm or more. The size threshold is the critical distinction from its companion code: 21011 covers the same anatomic territory for tumors under 2 cm. Per the CMS NCCI Correspondence Language Manual (2026), when both codes are billed at the same anatomic site, 21012 is considered the more extensive procedure and 21011 cannot be reported separately.

The 90-day global period means all routine post-op visits, dressing changes, and wound checks through day 90 are bundled into the surgical fee. Any separately identifiable E/M service on the day of surgery requires modifier 25. A new problem or unrelated procedure performed during the global window requires modifier 79.

This code is performed most frequently by Plastic and Reconstructive Surgery and Otolaryngology. It can be billed in an office or outpatient hospital setting — site of service affects payment materially, so confirm your place-of-service code matches where the procedure was actually performed.

RVU & reimbursement

Component RVUs and Medicare national rate. Actual payment varies by GPCI locality.

Source · CMS Physician Fee Schedule, RVU26A · January 2026

Work RVU vs. total RVU

The work RVU (4.34) is the surgeon's own effort — the figure physician pay and productivity targets are built on. The total RVU (9.7) adds practice overhead and malpractice, and is what drives the Medicare payment below.

Work RVU	4.34
Practice expense RVU	4.45
Malpractice RVU	0.91
Total RVU	9.7
Medicare national rate	$323.99
Global period	90 days

Payment by site of service

Medicare pays different rates by setting. HOPD typically pays substantially more than ASC for the same procedure.

Source · CMS OPPS Addendum B·ASC HCPCS payment rates·2026

Setting	Medicare rate (national)
Office (PFS non-facility) Procedure performed in physician's office	$323.99
HOPD (APC 5072) Hospital outpatient department	$1,687.37
ASC (PI R2) Ambulatory surgical center (freestanding)	$742.04

Common denial reasons

The recurring reasons claims for CPT 21012 get rejected.

Source · Editorial brief grounded in CMS NCCI edits, AAOS coding appeals, and cited references ↓

Upcoding from 21011: payer audits the measured size and downcodes if documentation shows the lesion was under 2 cm.
Unbundling 21011 and 21012 at the same anatomic site on the same date — NCCI edits prohibit billing both codes for the same lesion location.
Incorrect place-of-service code mismatching where the procedure was actually performed, triggering a site-of-service payment adjustment or denial.
Missing or vague tumor size documentation — 'small subcutaneous lesion' without a centimeter measurement gives auditors grounds to deny or downcode.
Modifier 25 absent when an E/M was billed same-day as the procedure, causing the E/M to be bundled and denied.

Frequently asked questions

Source · Generated from the editorial pipeline, verified against 5 cited references ↓

01What separates 21012 from 21011?

Size at the same anatomic site. 21011 is for subcutaneous face/scalp tumors under 2 cm; 21012 is for 2 cm or greater. When both are performed at different sites on the same date, bill with modifier 59 on the lesser procedure. When performed at the same site, only 21012 is billable — it's the more extensive code.

02Can 21011 and 21012 be billed together on the same claim?

Only if the excisions are at distinct, separate anatomic sites on the face or scalp. Use modifier 59 on 21011 to identify it as a distinct procedural service. Billing both for the same tumor location is an NCCI violation per the CMS 2026 Correspondence Language Manual.

03Does the 90-day global period apply to 21012?

Yes. The 90-day global bundles the day-before pre-op visit, the procedure itself, and all routine post-operative care through day 90. An unrelated procedure or E/M during that window requires modifier 79 or 24, respectively.

04Which modifier applies if the excision was significantly more difficult than typical — for example, due to tumor proximity to the facial nerve?

Modifier 22 (Increased Procedural Services). Support it with a detailed operative note quantifying the added complexity — vascular involvement, proximity to critical structures, or prolonged operative time. Without that documentation, payers will strip modifier 22 and reprocess at standard rate.

05Is a pathology report required for billing 21012?

CMS does not mandate a pathology report as a billing requirement, but most payers treat it as a medical necessity document. If the specimen was not sent to pathology and the diagnosis is later questioned, you have no supporting record. Best practice: send the specimen and retain the report.

06How does site of service affect reimbursement for 21012?

Substantially. The HOPD and ASC payment rates differ from the office non-facility rate. If you bill with a facility place-of-service but the procedure was performed in the office, or vice versa, the claim will either underpay or trigger a site-of-service audit. Match your POS code to where the procedure actually occurred.

Sources & references

Editorial content was developed using the following public sources. Last verified May 8, 2026.

01CMS Physician Fee Schedule 2026
02
cms.gov
https://www.cms.gov/files/document/medicare-ncci-correspondence-language-manual-02282026.pdf
03
mdclarity.com
https://www.mdclarity.com/cpt-code/21012
04
payerprice.com
https://payerprice.com/rates/21012-CPT-fee-schedule
05
aapc.com
https://www.aapc.com/codes/cpt-codes/21012

Mira AI Scribe

Mira's AI scribe captures the measured tumor dimensions, anatomic site (face vs. scalp), and confirmed subcutaneous depth directly from dictation — the three data points most likely to trigger a downcode to 21011 or a medical necessity denial when missing. It also flags if a same-day E/M was documented as significant and separately identifiable, prompting modifier 25 before the claim drops.

See how Mira captures CPT 21012 documentation